JB Pharma outlines key ESG goals & targets in Third Sustainability Report FY24
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Highly effective preservation solutions ensuring the safety and protection of personal care products
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Subscribe To Our Newsletter & Stay Updated